Nurix Therapeutics stockNRIX
Nurix Therapeutics trades at $14.84, 47.4% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. −21.8% year to date, +19.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 17, 2027.
Ratings, candles, signals and the screener for NRIX — after you log in
Open the terminalFrequently asked questions about Nurix Therapeutics
What is the Nurix Therapeutics stock price?
At the close on Nov 5, 2026: $14.84 (−6.96% on the day). 52-week high: $28.23 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Nurix Therapeutics report earnings?
The next quarterly report is on Feb 17, 2027. Last quarter, earnings per share changed +559% year over year, revenue +8,426%.
Does Nurix Therapeutics pay dividends?
No, Nurix Therapeutics does not pay dividends.
Where does Nurix Therapeutics trade and how to buy it?
Ticker NRIX, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Nurix Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NRIX are in the terminal after you log in.